Targeting arachidonic acid-related metabolites in COVID-19 patients: potential use of drug-loaded nanoparticles.

Shoieb, Sherif M; El-Ghiaty, Mahmoud A; El-Kadi, Ayman O S

Shoieb, Sherif M; El-Ghiaty, Mahmoud A; El-Kadi, Ayman O S.

Afiliação

Shoieb SM; Faculty of Pharmacy & Pharmaceutical Sciences, 2142J Katz Group-Rexall Centre for Pharmacy and Health Research, University of Alberta, Edmonton, Alberta T6G 2E1 Canada.
El-Ghiaty MA; Faculty of Pharmacy & Pharmaceutical Sciences, 2142J Katz Group-Rexall Centre for Pharmacy and Health Research, University of Alberta, Edmonton, Alberta T6G 2E1 Canada.
El-Kadi AOS; Faculty of Pharmacy & Pharmaceutical Sciences, 2142J Katz Group-Rexall Centre for Pharmacy and Health Research, University of Alberta, Edmonton, Alberta T6G 2E1 Canada.

Emergent Mater ; 4(1): 265-277, 2021.

Article em En | MEDLINE | ID: mdl-33225219

Palavras-chave

Arachidonic acid; COVID-19; Cytochrome P450; EETs; Nanoparticles; SARS-CoV-2; Subterminal HETEs

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article